Key result
In patients with decompensated heart failure, levosimendan reduced the need for diuretic doses to 10% compared to 25% with other inotropes, while also improving hemodynamic stability and reducing ICU stay.
Why the study?
Does levosimendan added to standard inotropes improve hemodynamics and clinical outcomes in patients with acute decompensated heart failure post-cardiac surgery?
Population
80 patients with decompensated heart problems
Comparison
Levosimendan (LIVO group) vs other inotropes (NON-LIVO group)
Design
Comparative trial
Authors
Loading...
May support levosimendan in decompensated HF; leaves open benefit when added to inotropes post-cardiac surgery.
Observational (n=80)
No
Does levosimendan added to standard inotropes improve hemodynamics and clinical outcomes in patients with acute decompensated heart failure post-cardiac surgery?
Absolute Event Rate: 10% vs 25%
The addition of levosimendan to standard inotropes in post-surgical patients with acute decompensated heart failure may improve hemodynamic stability and reduce ICU length of stay.
Dhaliwal et al. (2020) conducted an observational in Decompensated heart failure (n=80). Levosimendan vs. Other inotropes (noradrenaline, adrenaline, dobutamine) was evaluated on Diuretic use. In patients with decompensated heart failure, levosimendan reduced the need for diuretic doses to 10% compared to 25% with other inotropes, while also improving hemodynamic stability and reducing ICU stay.